Research Article
Diagnostic Value of Autoantibodies against Ezrin in Esophageal Squamous Cell Carcinoma
Table 1
Participant details and clinicopathological features.
| Group | ESCC | Normal |
| Number | 149 | 98 | Male, (%) | 107 (72%) | 70 (71%) | Female, (%) | 42 (28%) | 28 (29%) | Mean age ± s.d. (years) | 58 ± 9 | 55 ± 10 | Age range (years) | 41–88 | 34–87 | Tumor invasion depth | | | Tis | 4 | | T1 + T2 | 32 | | T3 + T4 | 113 | | Lymph node metastasis | | | Positive | 72 | | Negative | 77 | | Histological grade | | | High | 40 | | Medium | 93 | | Low | 16 | | TNM stage | | | 0 | 4 | | I | 14 | | II | 57 | | III | 44 | | III | 3 | | Tumor size | | | <5 cm | 89 | | ≥5 cm | 60 | | Tumor site | | | Upper thorax | 17 | | Middle thorax | 111 | | Lower thorax | 21 | |
|
|
ESCC: esophageal squamous cell carcinoma.
|